Please provide admissions figures (inpatient is fine) for financial years 2010-11 and 2011-12.
The Trust applies exemption 21(1) to this request, as this information for 2010/11 is available by other means. However, I wish to offer assistance and advice in the spirit of the Act and a link to the information is provided below;
The admission figures for 2011 – 12 are currently in draft format and are intended for future publication, therefore the Trust is applying Section 22 of the Freedom of Information Act. However, in the spirit of providing advice and assistance the Trust can advise that these figures will be published in the annual report once approved by Monitor and should be available by mid July.
Are there any reasons for the changes in figures? For example you may have increased bed numbers or had high/low numbers of winter illnesses.
There have been no significant changes in bed numbers but there is increased demand for day surgery, in particular Endoscopy.
The link at question one links to the Annual Report for 2010/11 which provides further information relating to admissions.
The information relating to 2011 – 12 is exempt as per question 1.
Do you expect the cost of your medical supplies (consumables and disposable products) to increase/remain the same/decrease in the new financial year (2012-13) compared to last year (2011-12). Please briefly explain why.
We expect all three (increase/decrease/remain the same) across the portfolio of products managed by procurement. Some items will be under existing contracts, some will be re-tendered and some renegotiated.
Does your hospital buy Covidien products (Covidien brands include: e.g. Autosuture, ev3, Kendall, Ligasure, Mallinckrodt, Nellcor, Puritan Bennett, SharpSafety, Shiley, Syneture, Valleylab)? Are their prices more or less as stable as other brands at the moment?
We buy Covidien products via a number of routes ie NHSSC where prices are agreed at a national level.
For the new financial year (2012-13), do you plan to consolidate your supplies and move towards large volume suppliers. (Yes or no, please explain why either way.)
We currently consolidate our purchasing wherever possible and utilise two prime distribution routes
Our view is to increase volumes through these two routes enabling greater aggregation and also supporting carbon reduction programs by minimising the volume of traffic delivering to the Trust.